Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 47 Leukemia, Myeloid, Acute 25 Recurrence 21 Lymphoma, Large B-Cell, Diffuse 13 Sarcoma 9 Lymphoma 6 Neoplasms, Plasma Cell 5 Neoplasm Metastasis 5 Glioblastoma 5 Endometrial Neoplasms 5 Ovarian Neoplasms 4 Neurofibrosarcoma 4 Neoplasms 4 Melanoma 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Non-Hodgkin 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Lymphoma, Extranodal NK-T-Cell 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2

Interventions

Paclitaxel 15 atezolizumab 11 Gemcitabine 11 Carboplatin 9 pembrolizumab 8 Docetaxel 8 Bevacizumab 8 Irinotecan 7 Injections 6 Cetuximab 6 Capecitabine 6 Sunitinib 5 Leucovorin 5 Fluorouracil 5 Cyclophosphamide 5 tocilizumab 4 pazopanib 4 olaparib 4 navitoclax 4 liposomal doxorubicin 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 temsirolimus 3 spartalizumab 3 lenvatinib 3 fludarabine 3 cobimetinib 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × selinexor × Clear all

NCT02078349 2020-09-10

Phase I Study of KPT330 in Asian Patients

National University Hospital, Singapore

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡